Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.281
Neutral
RSI(14)
53.750
Neutral
STOCH(KDJ)(9,3,3)
63.498
Sell
ATR(14)
0.403
High Vlolatility
CCI(14)
45.656
Neutral
Williams %R
34.441
Buy
TRIX(12,20)
0.179
Sell
StochRSI(14)
0.000
Oversold
Medifast Inc
MED11.430USD
-0.420-3.54%
Market hours （ET）Quotes delayed by 15 min
125.63MMarket Cap
499.56P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Medifast Inc
Currency: USD Updated: 2025-12-19Key Insights
Medifast Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 42/96 in the Food & Tobacco industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 15.00.In the medium term, the stock price is expected to trend down.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Medifast Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
2
analysts
Hold
Current Rating
15.000
Target Price
+32.04%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Medifast Inc Highlights
StrengthsRisks
Medifast, Inc. is a health and wellness company. The Company is engaged in offering habit-based and coach-guided lifestyle solution, OPTAVIA, which provides people with a comprehensive approach to address obesity and support a healthy lifestyle. OPTAVIA provides coaching support along with community, tailored nutrition, and healthy habits, and helps people in their weight-loss journey through each stage of life. Through its collaboration with national virtual primary care provider LifeMD, Inc. and its affiliated medical group, customers have access to GLP-1 medications where clinically appropriate. It sells a variety of weight-loss, weight management and healthy living products all based on its proprietary formulas under the OPTAVIA, OPTAVIA ACTIVE, and Optimal Health brands. Its product line includes approximately 79 consumable options, including bars, puffs, cereal, crunchers, drinks, hearty choices, oatmeal, pancakes, pudding, soft serve, shakes, smoothies, soft bakes, and soups.
Overvalued
The company’s latest PE is 517.92, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 8.80M shares, decreasing 28.51% quarter-over-quarter.
Held by PRFDX
Star Investor PRFDX holds 1.15K shares of this stock.
Financial Health
Currency: USD Updated: 2025-12-19The current financial score of Medifast Inc is 6.87, ranking 55/96 in the Food & Tobacco industry. Its financial status is robust, and its operating efficiency is average. Its latest quarterly revenue reached 89.41M, representing a year-over-year decrease of 36.21%, while its net profit experienced a year-over-year decrease of 300.27%.
Score
Financials
10.00
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
2.43
Operational Efficiency
7.99
Growth Potential
4.90
Shareholder Returns
9.05
Medifast Inc's Company Valuation
Currency: USD Updated: 2025-12-19The current valuation score of Medifast Inc is 8.68, ranking 14/96 in the Food & Tobacco industry. Its current P/E ratio is 517.92, which is 4.30% below the recent high of 540.21 and 104.26% above the recent low of -22.09.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 42/96
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2025-12-19The current earnings forecast score of Medifast Inc is 6.00, ranking 60/96 in the Food & Tobacco industry. The average price target for Medifast Inc is 15.00, with a high of 15.00 and a low of 15.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
2
analysts
Hold
Current Rating
15.000
Target Price
+32.04%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
56
Total
7
Median
9
Average
Company name
Ratings
Analysts
Medifast Inc
MED
2
Mondelez International Inc
MDLZ
28
Hershey Co
HSY
24
General Mills Inc
GIS
22
Kraft Heinz Co
KHC
22
International Flavors & Fragrances Inc
IFF
21
1
2
3
...
11
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2025-12-19The current price momentum score of Medifast Inc is 5.79, ranking 82/96 in the Food & Tobacco industry. Currently, the stock price is trading between the resistance level at 12.73 and the support level at 10.71, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
12.018
Sell
MA10
11.860
Sell
MA20
11.360
Buy
MA50
11.843
Sell
MA100
12.805
Sell
MA200
13.192
Sell
Institutional Confidence
Currency: USD Updated: 2025-12-19The current institutional shareholding score of Medifast Inc is 7.00, ranking 22/96 in the Food & Tobacco industry. The latest institutional shareholding proportion is 80.10%, representing a quarter-over-quarter increase of 1.77%. The largest institutional shareholder is James Simons, holding a total of 800.91K shares, representing 7.29% of shares outstanding, with 9.90% decrease in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Shareholder Activity
Name
Shares Held
Chg %
BlackRock Institutional Trust Company, N.A.
Charles Schwab Investment Management, Inc.
BofA Global Research (US)
Two Sigma Investments, LP
Acadian Asset Management LLC
Parametric Portfolio Associates LLC
AQR Capital Management, LLC
1
2
Risk Assessment
Currency: USD Updated: 2025-12-19The current risk assessment score of Medifast Inc is 5.89, ranking 47/96 in the Food & Tobacco industry. The company's beta value is 0.46. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.
Score
Beta vs S&P 500 index
0.49
VaR
+4.72%
240-Day Maximum Drawdown
+37.15%
240-Day Volatility
+44.17%
Return
Best Daily Return
60 days
+4.48%
120 days
+5.75%
5 years
+12.12%
Worst Daily Return
60 days
-5.42%
120 days
-5.42%
5 years
-22.47%
Sharpe Ratio
60 days
-1.94
120 days
-0.85
5 years
-1.13
Risk Assessment
Maximum Drawdown
240 days
+37.15%
3 years
+90.96%
5 years
+96.86%
Return-to-Drawdown Ratio
240 days
-0.77
3 years
-0.33
5 years
-0.20
Skewness
240 days
-0.21
3 years
-0.96
5 years
-0.63
Volatility
Realised Volatility
240 days
+44.17%
5 years
+49.29%
Standardised True Range
240 days
+4.62%
5 years
+34.81%
Downside Risk-Adjusted Return
120 days
-155.03%
240 days
-155.03%
Maximum Daily Upside Volatility
60 days
+21.02%
Maximum Daily Downside Volatility
60 days
+22.17%
Liquidity
Average Turnover Rate
60 days
+2.08%
120 days
+2.06%
5 years
--
Turnover Deviation
20 days
-33.15%
60 days
-23.28%
120 days
-24.15%
Peer Comparison
Food & Tobacco
Medifast Inc
MED
6.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Andersons Inc
ANDE
8.43 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Cal-Maine Foods Inc
CALM
8.32 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Post Holdings Inc
POST
8.18 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Turning Point Brands Inc
TPB
8.12 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Philip Morris International Inc
PM
8.12 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
FAQs
How does TradingKey generate the Stock Score of Medifast Inc?
The TradingKey Stock Score provides a comprehensive assessment of Medifast Inc based on 34 indicators derived from over 100 underlying data points. These indicators are categorised into six key dimensions: financial health, company profile, earnings forecasts, price momentum, institutional confidence, and risk assessment, collectively providing investors with a thorough analysis of Medifast Inc’s performance and outlook.
How do we generate the financial health score of Medifast Inc?
To generate the financial health score of Medifast Inc, we analyse various key financial indicators across several core dimensions, including financial fundamentals, earnings quality, operational efficiency, growth potential, and shareholder returns. By integrating these comprehensive data, the financial health score not only reflects Medifast Inc's overall stability, operational efficiency, and growth potential but also captures the investment returns delivered to shareholders. This score aims to support rational decision-making for investors and other stakeholders. A higher score indicates a better financial health of Medifast Inc.
How do we generate the company valuation score of Medifast Inc?
To generate the company valuation score of Medifast Inc, we use several key financial ratios, including P/E, P/B, P/S, and P/CF. These metrics compare Medifast Inc’s market value to its earnings, assets, sales, and cash flow, serving as core indicators for assessing company value. By analysing these ratios in an all-round manner, the valuation score reflects not only the market’s current perception of Medifast Inc’s value but also its future profitability and growth potential, thereby supporting more informed investment decisions. A higher score indicates a fairer valuation of Medifast Inc.
How do we generate the earnings forecast score of Medifast Inc?
To calculate the earnings forecast score of Medifast Inc, we consider various key indicators such as analyst ratings, financial forecasts, support and resistance levels, and peer comparisons:Current ratings and price targets directly reflect analysts’ expectations, while the upside space indicates their views on the stock’s growth potential.Financial metrics like earnings per share (EPS), revenue, net income, and earnings before interest and taxes (EBIT) are core measures for assessing profitability.By analysing the high, median, and low ranges of the target price, we can identify price trends and determine key support and resistance levels.Comparing these indicators against peers provides context for the stock’s performance and helps
anchor more realistic expectations.These factors together form a comprehensive earnings forecast score that accurately reflects the stock’s expected financial performance and growth potential. A higher score suggests that analysts have a more optimistic outlook on Medifast Inc’s future.
How do we generate the price momentum score of Medifast Inc?
When generating the price momentum score for Medifast Inc, we examine momentum indicators including support and resistance levels as well as volume metrics.Support levels represent price points where buying interest is strong enough to prevent further declines, while resistance levels indicate prices where selling pressure may hinder upward movement. By analysing typical price volume alongside total volume, we assess overall market activity and liquidity. These indicators help identify price trends and potential shifts, enabling more accurate predictions of future earnings.This comprehensive approach can reflect market sentiment and enable rational forecasts of Medifast Inc’s prices. A higher score indicates a more stable short-term price trend for Medifast Inc.
How do we generate the institutional confidence score of Medifast Inc?
To generate the institutional confidence score of Medifast Inc, we analyse both the proportion of shares held by institutions and the number of shares they own. A higher institutional ownership percentage indicates strong confidence of professional investors, which is generally a positive signal about Medifast Inc’s potential. By examining the number of shares held, we gain deeper insight into institutions’ commitment and attitude toward the stock, as institutional investors typically conduct thorough analysis before making investment decisions. Understanding institutional confidence helps us refine earnings forecasts and provides a more reliable perspective on the company’s future performance and market stability. A higher score indicates greater institutional endorsement of Medifast Inc.
How do we generate the risk management score of Medifast Inc?
To assess the risk management score of Medifast Inc, we examine multiple key indicators related to returns, risk, volatility, and liquidity.The highest and lowest daily returns reflect the potential size of gains and losses, while the Sharpe ratio measures risk-adjusted return performance. On the risk side, we analyse maximum drawdown and the return-to-drawdown ratio to identify extreme loss scenarios. Skewness helps assess the distribution of returns and whether performance may be biased. Volatility indicators—such as realised volatility and standardised true range—reveal price fluctuations. Downside risk-adjusted returns provide insight into potential losses and gains. Lastly, liquidity metrics like average turnover rate and turnover deviation indicate how actively the stock is traded.These indicators together provide a multi-dimensional understanding of Medifast Inc’s risk-return profile, serving as core factors of the risk management score. A higher score indicates lower risk on the side of Medifast Inc.
